ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Embargoed until September 26, 4:00 p.m. ET:

Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-Analysis (JCO PO: Original Report)
Doah Cho, et al.
Request this article

Embargoed until September 25, 4:00 p.m. ET:

Associations Between Sexual Orientation and Overall and Site-Specific Diagnosis of Cancer: Evidence From Two National Patient Surveys in England (JCO: Original Report)
Catherine Saunders, et al. 
Request this article

Embargoed until September 22, 4:00 p.m. ET:

No articles scheduled for publication. 

Embargoed until September 21, 4:00 p.m. ET:

Impact of Preexisting Mental Illness on All-Cause and Breast Cancer–Specific Mortality in Elderly Patients With Breast Cancer (JCO: Original Report) 
Melissa Santorelli, et al.
Request this article

High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors (JCO PO: Original Report)
Ralph Weissleder, et al.
Request this article

Embargoed until September 20, 4:00 p.m. ET:

Effect of Comorbidity on Prostate Cancer–Specific Mortality: A Prospective Observational Study (JCO: Original Report)
Prabhakar Rajan, et al.
Request this article

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis (JCO: Original Report) 
Ruben Mesa, et al.
Request this article

Embargoed until September 19, 4:00 p.m. ET:

Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial (JCO: Original Report)
Areej El-Jawahri, et al.
Request this article

Succeeding in Breaking the R-CHOP Ceiling in DLBCL: Learning From Negative Trials (JCO: Editorial) 
Andre Goy, et al.
Request this article

Has Province-Wide Symptom Screening Changed Opioid Prescribing Rates in Older Patients With Cancer? (JOP: Original Contribution)
Lisa Barbera, et al.
Request this article

Embargoed until September 18, 4:00 p.m. ET:

Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors (JCO: Original Report) 
Talya Salz, et al.
Request this article

Embargoed until September 15, 4:00 p.m. ET:

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma (JCO: Original Report) 
Mario Sznol, et al.
Request this article

Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission (JCO PO: Original Report) 
Jan J. Cornelissen, et al. 
Request this article


Embargo Information

The embargo date and time of a journal article coincides with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year, and may affect broader ASCO media privileges as well.  Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.